This page features an assortment of drug(s) that could potentially trigger 'Intestinal obstruction' as a Side-effect
or adverse response. It is not uncommon for medications to have some tolerable mild side effects.
Do remember that these listed medication(s) only represents individual medications that could be part of a larger combination therapy. Please keep in mind that this list of drug(s) is intended to serve as an information resource and should not be a substitute to professional medical advice. If you have concerns about 'Intestinal obstruction
', we advise that you speak with a healthcare professional.
Similar to 'Intestinal obstruction
,' there are other symptoms or signs that might more accurately describe your side effect. They are detailed below for your convenience. If any of these additional symptom(s) align more closely with your experience, you can choose them to determine potential medications that could be responsible.
Drugs with the Side Effect - Intestinal obstruction
Most other Common Side Effects:
Abdominal pain, diarrhea
Find drugs that can cause other symptoms like 'Intestinal obstruction'
Search Side effects by name
Recently Added Drugs
Algeldrate is prescribed as a gastric antacid in adults.
Amtolmetin guacil is prescribed for Rheumatoid arthritis in Adults and Children above 2 years .
Gastrointestinal disorders: Bacillus clausii is commonly used as a probiotic to help restore the natural balance of bacteria within the gut, especially during or after a course of antibiotics.
Amylmetacresol is prescribed for the treatment of sore throat and oral infections.
Inositol is prescribed in PCOS as it helps in balancing certain hormones in the patients with this condition.
Margetuximab is an anticancer agent indicated for the treatment of breast cancer.
Isatuximab is an anticancer agent indicated for the treatment of adults with multiple myeloma.
Pralsetinib is indicated for the treatment of adults with non-small cell lung cancer (NSCLC), based on the presence of a specific gene fusion named RET.
Pemigatinib is an anticancer agent indicated for the treatment of bile duct cancer or cholangiocarcinoma.
Belantamab is an anticancer agent indicated for the treatment of adults with multiple myeloma-A type of skin cancer.